BURBANK, Calif., June 7, 2006 (PRIMEZONE) -- Imaging3(tm), Inc, (OTCBB:IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, today provided an overview of its upcoming new product, The Dominion(tm) and the advancements it is seeking to deliver to the spinal surgery market. Bio-technological leaps in implantable spinal immobilization devices and advances in our understanding of cell biology, including stem cell developments, are expected to propel the rapid growth of this market sector over the next several years. This growth will require ever more detailed fields of vision during surgery, and the real-time 3D images from Imaging3's Dominion product are expected to be a major part of this rapidly developing sector.
According to P&M Corporate Finance, LLC. of Detroit, MI, as surgeons continue their efforts to combat back pain and increase patient satisfaction, spinal implants are the fastest growing segment of the orthopedic market. Reaching over $3.7 billion in 2004, the market is expected to expand to over $7.4 billion by 2010, representing a compound annual growth rate (CAGR) OF 12.1 percent over the six-year period. The rapid growth projected in this sector is driven primarily by new technologies, advances in minimally invasive surgical procedures, and favorable demographic trends.
"Over the next decade or more, a continued reliance on fusion technologies, dynamic stabilization and the increased use of minimally invasive procedures will necessitate the need for an improved visual field in the spinal surgical suite," said Dean Janes, Imaging3's CEO. "The Dominion(tm), with its unprecedented real time 3D imaging, will provide physicians a much greater degree of accuracy and increased performance and speed while performing these procedures. By being able to view the human body in 3D in real time, the physician will more accurately diagnose and treat patients with spinal disease and disorders."
About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at www.imaging3.com
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.